GraftWorx is honored to be nominated as a 1st Round Finalist, a Top 10 company, in the Best Cardiovascular Digital Diagnostic category for in the 2019 UCSF Health Awards! Read full article Related Articles June 30, 2021Alio Raises $20M in Series B FinancingPress Release April 6, 2021Predictions & Insights: As the pandemic comes to a close – what’s next?Blog March 30, 2021Alio Announces Eric Hargan joining Board of DirectorsPress Release February 24, 2021Alio Completes First Pilot Study of SmartPatch in Intermountain Healthcare PartnershipPress Release February 3, 2021Alio recognized by Kidney X as winner for Remote Monitoring PlatformMedia Coverage November 10, 2020Alio Introduces Series of Studies for Clinical-Grade Noninvasive WearablePress Release November 4, 2020Introducing our new brand, Alio.Blog August 24, 2020Ushering in a New Era of Innovation for Chronic Condition ManagementBlog August 13, 20202020 Prime Health Challenge Semifinalist AnnouncementMedia Coverage March 26, 2020GraftWorx named winner in inaugural KidneyX Patient Innovator ChallengeMedia Coverage
